BRG-399

N/A

Report date: 2022/04/18 10:49:26
NME

Base Information

Drug NameBRG-399
Drug Alias NameBRG-399
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUbiquitin-conjugating enzyme E2 K modulators
TargetsUbiquitin-conjugating enzyme E2 K
Therapy Area/IndicationsStomach Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBerg Llc
China Registration ClassN/A

Develop Information

Active CompaniesBerg Llc
Inactive CompaniesN/A
Active IndicationsStomach Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A